Demonstration of a shear-based solid-state phase transformation in a small molecular organic system: Chlorpropamide

Journal of Pharmaceutical Sciences

Volumn 96, Issue 5, 2007, Pages 1100-1113

  Wildfong, Peter L D ^a   Morris, Kenneth R ^b   Anderson, Carl A ^a   Short, Steven M ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Polymorphism; Raman spectroscopy; Solid state; Transformation; X ray powder diffractometry

Indexed keywords

CHLORPROPAMIDE; ORGANIC MATTER;

ARTICLE; CRYSTAL STRUCTURE; HIGH TEMPERATURE; HYDROSTATIC PRESSURE; POWDER; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; SHEAR STRESS; SOLID STATE; X RAY DIFFRACTION;

EID: 34249073486     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20920     Document Type: Article

References (47)

1. Johnson WL. 1986. Thermodynamic and kinetic aspects of the crysal to glass transformation in metallic materials. Prog Mater Sci 30:81-134.
2. Lewis D, Northwood DO, Reeve RC. 1969. Strain induced phase transformation in lead monoxide. J Appl Cryst 2:156-164.
3. Imamura K, Senna M. 1984. Difference between mechanochemical and thermal processes of polymorphic transformation of ZnS and PbO. Mater Res Bull 19:59-65.
4. Isobe T, Senna M. 1990. Control of lithargemassicot transformation by doping and mechanical activation. React Solids 8:29-40.
5. Katzke H, Schlogl R. 2003. Mechanism of the morphotropic transformation between the rutile and corundum structural types. Acta Cryst B59: 456-462.
6. 3). Solid State Commun 123:195-200.
7. 2. Mater Chem Phys 80:73-81.
8. 2 during high energy milling. J Mater Sci 35:6015-6026.
9. 2). J Phys Condens Matter 13: 8317-8323.
10. Brittain HG. 2002. Effects of mechanical processing on phase composition. J Pharm Sci 91:1573-1580.
11. Morris KR, Nail SL, Peck GE, Byrn SR, Griesser UJ, Hwang S-J, Park K. 1998. Advances in pharmaceutical materials and processing. Pharm Sci Tech Today 1:235-245.
12. Boldyrev VV, Tkacova K. 2000. Mechanochemistry of solids: Past, present and future. J Mat Synth Proc 8:121-132.
13. DHHS/FDA. 2000. International conference on harmonisation: guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. Federal Register 65: 83041-83063.
14. Byrn SR, Pfeiffer R, Ganey M, Hoiberg C, Poochikian G. 1995. Pharmaceutical solids: A strategic approach to regulatory considerations. Pharm Res 12:945-954.
15. Sun C, Grant DJW. 2001. Compaction properties of L-lysine salts. Pharm Res 18:281-286.
16. Sun C, Grant DJW. 2001. Influence of crystal shape on the tableting performance of L-lysine monohydrate dihydrate. J Pharm Sci 90:569-579.
17. Chan HK, Doelker E. 1985. Polymorphic transformation of some drugs under compression. Drug Dev Ind Pharm 11:315-332.
18. Cruaud O, Duchene D, Puisieux F, Chauvet A, Masse J. 1981. Etude des transformations polymorphiques du sulfaniliamide au cours de la fabrication de comprimes. J Pharm Belg 36:15-20.
19. Desai SR, Shaikh MM, Dharwadkar SR. 2003. Thermoanalytical study of polymorphic transformation in Fluconazole drug. Thermochim Acta 399:81-89.
20. Shakhtshneider TP, Boldyrev W. 1993. Phase transformations in sulfathiazole during mechanical activation. Drug Dev Ind Pharm 19:2055-2067.
21. Sharma SM, Vijayakumar V, Sikka SK, Chidambaram R. 1985. High pressure phase transitions in organic solids I: a-b Transition in resorcinol. Pramana J Phys 25:75-79.
22. Wang SL, Lin SY, Wei YS. 2002. Transformation of metastable forms of acetaminophen studied by thermal Fourier transform infrared (FT-IR) microspectroscopy. Chem Pharm Bull 50:153-156.
23. Willart JF, De Gusseme A, Hemon S, Odou G, Danede F, Descamps M. 2001. Direct crystal to glass transformation of trehalose induced by ball milling. Solid State Commun 119:501-505.
24. Yajima K, Okahira A, Hoshino M. 1997. Transformation of lactitol crystals and dehydration with grinding. Chem Pharm Bull 45:1677-1682.
25. Simmons DL, Ranz RJ, Gyanchandani ND. 1973. Polymorphism in pharmaceuticals III. Chlorpropamide. Can J Pharm Sci 8:125-127.
26. Ueda H, Nambu N, Nagai T. 1984. Dissolution behavior of chlorpropamide polymorphs. Chem Pharm Bull 32:244-250.
27. Otsuka M, Matsumoto T, Kaneniwa N. 1989. Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide. J Pharm Pharmacol 41:665-669.
28. Ruoff AL. 1991. High pressure phase transformations. In: Cahn RW, Haasen P, Kramer EJ, editors. Phase transformations in materials. New York: VCH Publishers, Inc. pp 473-495.
29. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I: Theory of thermodynamic rules. Mikrochim Acta II:259-271.
30. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. II. Mikrochimica Acta II 273-316.
31. Sharma SM, Sikka SK. 1996. Pressure induced amorphization of materials. Prog Mater Sci 40:1-77.
32. DeVilliers MM, Wurster DE. 1999. Isothermal interconversion of chlorpropamide polymorphs kinetically quantified by X-ray powder diffractometry, diffuse reflectance Fourier transform infrared spectroscopy and isoperibol solution calorimetry. Acta Pharm 49:79-88.
33. Wildfong PLD, Morley NA, Moore MD, Morris KR. 2005. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry II. Data correction for analysis of phase transformations as a function of pressure. J Pharm Biomed Anal 39:1-7.
34. Koo CH, Cho SI, Yeon YH. 1980. The crystal and molecular structure of chlorpropamide. Arch Pharmacal Res 3:37-49.
35. Stahl K, Thomasson R. 1992. Using CPS120 (Curved Position-Sensitive Detector Covering 120°) powder diffraction data in rietveld analysis, the dehydration process in the zeolite thomsonite. J Appl Cryst 25:251-258.
36. Gao N, Ponomarev IY, Xiao QF, Gibson WM, Carpenter DA. 1996. Monolithic polycapillary focusing optics and their applications in microbeam X-ray fluorescence. Appl Phys Lett 69:1529-1531.
37. Cao W, Bates S, Peck GE, Wildfong PLD, Qiu Z, Morris KR. 2002. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry. J Pharm Biomed Anal 30:1111-1119.
38. Neumann MA. 2003. X-cell: A novel indexing algorithm for routine tasks and difficult cases. J Appl Cryst 36:356-365.
39. Engel GE, Wilke S, Konig O, Harris KDM, Leusen FJJ. 1999. PowderSolve - A complete package for crystal structure solution from powder diffraction patterns. J Appl Cryst 32:1169-1179.
40. Pawley GS. 1981. Unit-cell refinement from powder diffraction scans. J Appl Cryst 14:357-361.
41. Rietveld HM. 1969. A profile refinement method for nuclear and magnetic structures. J Appl Cryst 2: 65-71.
42. Mayo SL, Olafson BD, Goddard WA III, 1990. DREIDING: A generic force field for molecular simulations. J Phys Chem 94:8897-8909.
43. Rappe AK, Goddard IIIWA. 1991. Charge equilibration for molecular-dynamics simulations. J Phys Chem 95:3358-3363.
44. Osborn JC, York P, Rowe RC, Roberts RJ. 1999. Proceedings from the 14th International Symposium on Industrial Crystalization, Cambridge, UK, pp 1166-1174.
45. Cao W. 2002. Crystal Form Changes Under Compression. PhD Dissertation, Purdue University, West Lafayette, IN: Department of Industrial and Physical Pharmacy, pp 245.
46. Otsuka M, Matsuda Y. 1993. Effects of environmental temperature and compression energy on polymorphic transformation during tabletting. Drug Dev Ind Pharm 19:2241-2269.
47. Bowman K. 2004. Mechanical behavior of materials, editors. Haboken, NJ: John Wiley & Sons, pp 334.